Twist Bioscience SVP Paula Green sells $48,654 in common stock

Twist Bioscience Senior Vice President of Human Resources, Paula Green, sold 294 shares of company stock valued at $48,654 on September 21, 2026. This sale occurred as the stock price hovered near its 52-week high of $186.20, marking a 579% increase in value over the past year. The transaction was not an arbitrary decision but a necessary move to fulfill tax withholding requirements due to the vesting of Restricted Stock Units, as stipulated by Twist Bioscience's equity incentive plans.

Post this sale, Green still retains 116,720 shares in the company. Analysts suggest the stock may be overvalued at its current price, with Guggenheim maintaining a Buy rating while BWS Financial issued a Sell rating, citing intense competition in the life sciences market from firms like Danaher and Roche Holding.